21st.BIO Email Format
Biotechnology ResearchHovedstaden, Denmark51-200 Employees
21st.BIO is a biotechnology research company founded in 2020 and headquartered in Søborg, Hovedstaden, Denmark. It focuses on developing industrial production technology for proteins and other molecules used in food, nutrition, agriculture, biomaterials, and biomining, aiming to bridge the gap between innovation and commercial-scale manufacturing. The company operates as an end-to-end partner, supporting clients from assessment and strain development through upscaling, tech transfer to large-scale manufacturing, and regulatory services, with part of its fermentation platform licensed from Novonesis. It maintains laboratories in Copenhagen and Davis, California as part of its global R&D footprint. The target customers are bioindustrial companies seeking to translate molecule innovations to market, facing production-cost barriers that impede mainstream adoption. In May 2024, 21st.BIO announced a new pilot plant facility to accelerate the impact of biotech innovations globally.